Texas 2023 - 88th Regular

Texas Senate Bill SB2212

Filed
3/9/23  
Out of Senate Committee
4/25/23  
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the disclosure by a pharmacy to a patient of certain price information for a drug or biological product.

Impact

The passage of SB2212 is expected to notably impact state health laws, particularly those governing pharmacy practices and drug pricing transparency. By enforcing these disclosure requirements, the legislation seeks to promote competition among pharmacies, as patients will be empowered to shop around for cheaper alternatives. This could potentially lead to greater accountability within the pharmaceutical sector and incentivize pharmacies to offer better pricing to attract customers.

Summary

Senate Bill 2212 aims to enhance price transparency in the pharmaceutical market by requiring pharmacies to disclose the lowest cash price of prescribed drugs or biological products. Specifically, the bill mandates that if the cash price is lower than the copayment required under a patient's drug insurance plan, pharmacists must inform the patient of this lower cost option. The intent is to allow patients to make informed financial decisions regarding their medications, potentially saving them money on prescriptions.

Sentiment

Overall, the sentiment surrounding SB2212 has been largely positive. Supporters, including organizations like the AARP and Texans for Affordable Health Care, have voiced strong endorsements of the bill. They argue that it addresses the pressing issue of rising drug costs and advocates for consumer rights by providing critical price information. This support underscores a collective push towards improving healthcare accessibility and affordability for residents.

Contention

Despite the general support, there were points of contention regarding the bill's implementation and effectiveness. Some opponents may question the practicality of enforcing such disclosure rules and whether they will translate into real savings for patients. Concerns were also raised about potential pushback from some pharmacy chains that may be resistant to changes in pricing strategy. Nonetheless, these discussions have prompted further debate about the best approaches to creating sustainable and transparent healthcare solutions in Texas.

Texas Constitutional Statutes Affected

Occupations Code

  • Chapter 562. Practice By License Holder
    • Section: 003
    • Section: 003
    • Section: 003

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.